MedPath

Bevacizumab and Sorafenib in Treating Patients With Recurrent Glioblastoma Multiforme

Phase 2
Completed
Conditions
Brain and Central Nervous System Tumors
Interventions
Biological: bevacizumab
Registration Number
NCT00621686
Lead Sponsor
Alliance for Clinical Trials in Oncology
Brief Summary

RATIONALE: Monoclonal antibodies, such as bevacizumab, can block tumor growth in different ways. Some block the ability of tumor cells to grow and spread. Others find tumor cells and help kill them or carry tumor-killing substances to them. Sorafenib may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth. Bevacizumab and sorafenib may also stop the growth of tumor cells by blocking blood flow to the tumor. Giving bevacizumab together with sorafenib may kill more tumor cells.

PURPOSE: This phase II trial is studying the side effects and how well giving bevacizumab together with sorafenib works in treating patients with recurrent glioblastoma multiforme.

Detailed Description

OBJECTIVES:

Primary

* Identify the clinical efficacy of bevacizumab and sorafenib, as measured by 6-month progression-free survival, in patients with recurrent glioblastoma multiforme.

Secondary

* Assess time to progression of this patient population.

* Assess overall survival of this patient population.

OUTLINE: This is a multicenter study.

Patients receive oral sorafenib once daily on days 1-14 and bevacizumab IV over 30-90 minutes on day 1. Courses repeat every 14 days in the absence of disease progression or unacceptable toxicity.

Patients undergo blood and plasma sample collection at baseline and then periodically during study treatment for translational research studies. Translational research studies include analysis of circulating endothelial cells and circulating endothelial progenitor cells by flow cytometry and measurement of angiogenic proteins in plasma by ELISA. DNA and buffy coat are extracted and collected from the blood samples for pharmacogenetic studies.

Quality of life is assessed at baseline, prior to every other treatment course, and at the end of treatment.

After completion of study treatment, patients are followed at 28-42 days, every 3 months for 5 years, and then annually for 10 years.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
54
Inclusion Criteria

Not provided

Exclusion Criteria

Not provided

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
Sorafenib + Bevacizumab/Group Asorafenib tosylatePatients receive oral sorafenib 400 mg (200 mg twice daily) days 1-5 and 8-12 and 5 mg/kg bevacizumab IV over 30-90 minutes on day 1. Courses repeat every 14 days. Patients undergo blood and plasma sample collection at baseline and then periodically during study treatment for translational research studies. Translational research studies include analysis of circulating endothelial cells and circulating endothelial progenitor cells by flow cytometry and measurement of angiogenic proteins in plasma by ELISA. DNA and buffy coat are extracted and collected from the blood samples for pharmacogenetic studies. Quality of life is assessed at baseline, prior to every other treatment course, and at the end of treatment. After completion of study treatment, patients are followed at 28-42 days, every 3 months for 5 years, and then annually for 10 years.
Sorafenib + Bevacizumab /Group Bsorafenib tosylatePatients receive oral sorafenib 200 mg once daily on days 1-14 and 5 mg/kg bevacizumab IV over 30-90 minutes on day 1. Courses repeat every 14 days. Patients undergo blood and plasma sample collection at baseline and then periodically during study treatment for translational research studies. Translational research studies include analysis of circulating endothelial cells and circulating endothelial progenitor cells by flow cytometry and measurement of angiogenic proteins in plasma by ELISA. DNA and buffy coat are extracted and collected from the blood samples for pharmacogenetic studies. Quality of life is assessed at baseline, prior to every other treatment course, and at the end of treatment. After completion of study treatment, patients are followed at 28-42 days, every 3 months for 5 years, and then annually for 10 years.
Sorafenib + Bevacizumab/Group AbevacizumabPatients receive oral sorafenib 400 mg (200 mg twice daily) days 1-5 and 8-12 and 5 mg/kg bevacizumab IV over 30-90 minutes on day 1. Courses repeat every 14 days. Patients undergo blood and plasma sample collection at baseline and then periodically during study treatment for translational research studies. Translational research studies include analysis of circulating endothelial cells and circulating endothelial progenitor cells by flow cytometry and measurement of angiogenic proteins in plasma by ELISA. DNA and buffy coat are extracted and collected from the blood samples for pharmacogenetic studies. Quality of life is assessed at baseline, prior to every other treatment course, and at the end of treatment. After completion of study treatment, patients are followed at 28-42 days, every 3 months for 5 years, and then annually for 10 years.
Sorafenib + Bevacizumab /Group BbevacizumabPatients receive oral sorafenib 200 mg once daily on days 1-14 and 5 mg/kg bevacizumab IV over 30-90 minutes on day 1. Courses repeat every 14 days. Patients undergo blood and plasma sample collection at baseline and then periodically during study treatment for translational research studies. Translational research studies include analysis of circulating endothelial cells and circulating endothelial progenitor cells by flow cytometry and measurement of angiogenic proteins in plasma by ELISA. DNA and buffy coat are extracted and collected from the blood samples for pharmacogenetic studies. Quality of life is assessed at baseline, prior to every other treatment course, and at the end of treatment. After completion of study treatment, patients are followed at 28-42 days, every 3 months for 5 years, and then annually for 10 years.
Primary Outcome Measures
NameTimeMethod
6-month Progression-free Survivalat 6 months

Primary Endpoint: 6-month progression free survival (PFS6): The proportion of successes will be estimated using the binomial point estimator (number of successes divided by the total number of evaluable patients) and the binomial 95% confidence interval estimated. To be classified as a success, an evaluable patient must be alive and progression-free 6 months after registration to the study. Patients who die prior to 6 months after study registration will be considered to have failed. Progression is defined as a \>25% increase in product of perpendicular diameters of contrast enhancement or mass or appearance of new lesions or unequivocal increase in size of contrast enhancement or increase in mass effect as agreed upon independently by primary physician and quality control physicians: appearance of new lesions compared to pretreatment MRI and/or CT scan.

Secondary Outcome Measures
NameTimeMethod
Overall SurvivalTime from date of registration to a) date of death due to any cause or b) last follow-up; Up to 15 years

Overall survival (OS) is defined as the length of time from date of registration to a) date of death due to any cause or b) last follow-up.

Time to ProgressionTime from study registration to a) date of disease progression, or b) last follow-up; Up to 15 years

Time to progression (TTP) is defined to be the length of time from study registration to a) date of disease progression as defined by section 11.0 of the protocol, or b) last follow-up. If a patient dies without documentation of disease progression, the patient will be considered to have had a tumor progression at the time of death unless there is sufficient documented evidence to conclude no progression occurred prior to death. Time to progression curves were compared via the log-rank test. Progression is defined as a \>25% increase in product of perpendicular diameters of contrast enhancement or mass or appearance of new lesions or unequivocal increase in size of contrast enhancement or increase in mass effect as agreed upon independently by primary physician and quality control physicians: appearance of new lesions compared to pretreatment MRI and/or CT scan.

Trial Locations

Locations (202)

Mayo Clinic Scottsdale

🇺🇸

Scottsdale, Arizona, United States

Cancer Care Associates

🇺🇸

Fresno, California, United States

Front Range Cancer Specialists

🇺🇸

Fort Collins, Colorado, United States

Saint Francis/Mount Sinai Regional Cancer Center at Saint Francis Hospital and Medical Center

🇺🇸

Hartford, Connecticut, United States

Baptist Cancer Institute - Jacksonville

🇺🇸

Jacksonville, Florida, United States

Mayo Clinic - Jacksonville

🇺🇸

Jacksonville, Florida, United States

Rush-Copley Cancer Care Center

🇺🇸

Aurora, Illinois, United States

CCOP - Carle Cancer Center

🇺🇸

Urbana, Illinois, United States

Carle Cancer Center at Carle Foundation Hospital

🇺🇸

Urbana, Illinois, United States

St. Francis Hospital and Health Centers - Beech Grove Campus

🇺🇸

Beech Grove, Indiana, United States

Cedar Rapids Oncology Associates

🇺🇸

Cedar Rapids, Iowa, United States

Reid Hospital & Health Care Services

🇺🇸

Richmond, Indiana, United States

McFarland Clinic, PC

🇺🇸

Ames, Iowa, United States

Medical Oncology and Hematology Associates - West Des Moines

🇺🇸

Clive, Iowa, United States

Mercy Regional Cancer Center at Mercy Medical Center

🇺🇸

Cedar Rapids, Iowa, United States

Mercy Medical Center - Sioux City

🇺🇸

Sioux City, Iowa, United States

McCreery Cancer Center at Ottumwa Regional

🇺🇸

Ottumwa, Iowa, United States

Siouxland Hematology-Oncology Associates, LLP

🇺🇸

Sioux City, Iowa, United States

St. Luke's Regional Medical Center

🇺🇸

Sioux City, Iowa, United States

Cancer Center of Kansas-Independence

🇺🇸

Independence, Kansas, United States

Southwest Medical Center

🇺🇸

Liberal, Kansas, United States

Cancer Center of Kansas, PA - Salina

🇺🇸

Salina, Kansas, United States

Cancer Center of Kansas, PA - Medical Arts Tower

🇺🇸

Wichita, Kansas, United States

Hickman Cancer Center at Bixby Medical Center

🇺🇸

Adrian, Michigan, United States

Oakwood Cancer Center at Oakwood Hospital and Medical Center

🇺🇸

Dearborn, Michigan, United States

Green Bay Oncology, Limited - Escanaba

🇺🇸

Escanaba, Michigan, United States

Genesys Hurley Cancer Institute

🇺🇸

Flint, Michigan, United States

Hurley Medical Center

🇺🇸

Flint, Michigan, United States

Van Elslander Cancer Center at St. John Hospital and Medical Center

🇺🇸

Grosse Pointe Woods, Michigan, United States

Foote Memorial Hospital

🇺🇸

Jackson, Michigan, United States

Dickinson County Healthcare System

🇺🇸

Iron Mountain, Michigan, United States

Haematology-Oncology Associates of Ohio and Michigan, PC

🇺🇸

Lambertville, Michigan, United States

Sparrow Regional Cancer Center

🇺🇸

Lansing, Michigan, United States

St. Mary Mercy Hospital

🇺🇸

Livonia, Michigan, United States

Community Cancer Center of Monroe

🇺🇸

Monroe, Michigan, United States

St. Joseph Mercy Oakland

🇺🇸

Pontiac, Michigan, United States

Mercy Memorial Hospital - Monroe

🇺🇸

Monroe, Michigan, United States

Seton Cancer Institute at Saint Mary's - Saginaw

🇺🇸

Saginaw, Michigan, United States

MeritCare Bemidji

🇺🇸

Bemidji, Minnesota, United States

Mercy Regional Cancer Center at Mercy Hospital

🇺🇸

Port Huron, Michigan, United States

St. John Macomb Hospital

🇺🇸

Warren, Michigan, United States

Duluth Clinic Cancer Center - Duluth

🇺🇸

Duluth, Minnesota, United States

Mercy and Unity Cancer Center at Mercy Hospital

🇺🇸

Coon Rapids, Minnesota, United States

Fairview Ridges Hospital

🇺🇸

Burnsville, Minnesota, United States

CCOP - Duluth

🇺🇸

Duluth, Minnesota, United States

Miller - Dwan Medical Center

🇺🇸

Duluth, Minnesota, United States

Fairview Southdale Hospital

🇺🇸

Edina, Minnesota, United States

Fergus Falls Medical Group, PA

🇺🇸

Fergus Falls, Minnesota, United States

Mercy and Unity Cancer Center at Unity Hospital

🇺🇸

Fridley, Minnesota, United States

Hutchinson Area Health Care

🇺🇸

Hutchinson, Minnesota, United States

HealthEast Cancer Care at St. John's Hospital

🇺🇸

Maplewood, Minnesota, United States

Minnesota Oncology Hematology, PA - Maplewood

🇺🇸

Maplewood, Minnesota, United States

Hubert H. Humphrey Cancer Center at North Memorial Outpatient Center

🇺🇸

Robbinsdale, Minnesota, United States

CCOP - Metro-Minnesota

🇺🇸

Saint Louis Park, Minnesota, United States

CentraCare Clinic - River Campus

🇺🇸

Saint Cloud, Minnesota, United States

Coborn Cancer Center

🇺🇸

Saint Cloud, Minnesota, United States

Regions Hospital Cancer Care Center

🇺🇸

Saint Paul, Minnesota, United States

Park Nicollet Cancer Center

🇺🇸

Saint Louis Park, Minnesota, United States

United Hospital

🇺🇸

Saint Paul, Minnesota, United States

St. Francis Cancer Center at St. Francis Medical Center

🇺🇸

Shakopee, Minnesota, United States

Ridgeview Medical Center

🇺🇸

Waconia, Minnesota, United States

Minnesota Oncology Hematology, PA - Woodbury

🇺🇸

Woodbury, Minnesota, United States

CCOP - Columbus

🇺🇸

Columbus, Ohio, United States

Doctors Hospital at Ohio Health

🇺🇸

Columbus, Ohio, United States

CCOP - Cancer Research for the Ozarks

🇺🇸

Springfield, Missouri, United States

Hulston Cancer Center at Cox Medical Center South

🇺🇸

Springfield, Missouri, United States

St. John's Regional Health Center

🇺🇸

Springfield, Missouri, United States

CCOP - Montana Cancer Consortium

🇺🇸

Billings, Montana, United States

Montana Cancer Center at St. Patrick Hospital and Health Sciences Center

🇺🇸

Missoula, Montana, United States

Rutherford Hospital

🇺🇸

Rutherfordton, North Carolina, United States

Bismarck Cancer Center

🇺🇸

Bismarck, North Dakota, United States

Medcenter One Hospital Cancer Care Center

🇺🇸

Bismarck, North Dakota, United States

Mid Dakota Clinic, PC

🇺🇸

Bismarck, North Dakota, United States

St. Alexius Medical Center Cancer Center

🇺🇸

Bismarck, North Dakota, United States

MeritCare Broadway

🇺🇸

Fargo, North Dakota, United States

Mary Rutan Hospital

🇺🇸

Bellefontaine, Ohio, United States

Wood County Oncology Center

🇺🇸

Bowling Green, Ohio, United States

Adena Regional Medical Center

🇺🇸

Chillicothe, Ohio, United States

Grant Medical Center Cancer Care

🇺🇸

Columbus, Ohio, United States

Riverside Methodist Hospital Cancer Care

🇺🇸

Columbus, Ohio, United States

North Coast Cancer Care - Clyde

🇺🇸

Clyde, Ohio, United States

Mount Carmel Health - West Hospital

🇺🇸

Columbus, Ohio, United States

Grandview Hospital

🇺🇸

Dayton, Ohio, United States

Good Samaritan Hospital

🇺🇸

Dayton, Ohio, United States

David L. Rike Cancer Center at Miami Valley Hospital

🇺🇸

Dayton, Ohio, United States

Samaritan North Cancer Care Center

🇺🇸

Dayton, Ohio, United States

CCOP - Dayton

🇺🇸

Dayton, Ohio, United States

Grady Memorial Hospital

🇺🇸

Delaware, Ohio, United States

Hematology Oncology Center

🇺🇸

Elyria, Ohio, United States

Blanchard Valley Medical Associates

🇺🇸

Findlay, Ohio, United States

Middletown Regional Hospital

🇺🇸

Franklin, Ohio, United States

Wayne Hospital

🇺🇸

Greenville, Ohio, United States

Charles F. Kettering Memorial Hospital

🇺🇸

Kettering, Ohio, United States

Lima Memorial Hospital

🇺🇸

Lima, Ohio, United States

Fairfield Medical Center

🇺🇸

Lancaster, Ohio, United States

Northwest Ohio Oncology Center

🇺🇸

Maumee, Ohio, United States

Strecker Cancer Center at Marietta Memorial Hospital

🇺🇸

Marietta, Ohio, United States

St. Luke's Hospital

🇺🇸

Maumee, Ohio, United States

Licking Memorial Cancer Care Program at Licking Memorial Hospital

🇺🇸

Newark, Ohio, United States

Fisher-Titus Medical Center

🇺🇸

Norwalk, Ohio, United States

Toledo Clinic - Oregon

🇺🇸

Oregon, Ohio, United States

St. Charles Mercy Hospital

🇺🇸

Oregon, Ohio, United States

North Coast Cancer Care, Incorporated

🇺🇸

Sandusky, Ohio, United States

Community Hospital of Springfield and Clark County

🇺🇸

Springfield, Ohio, United States

Flower Hospital Cancer Center

🇺🇸

Sylvania, Ohio, United States

Toledo Hospital

🇺🇸

Toledo, Ohio, United States

St. Vincent Mercy Medical Center

🇺🇸

Toledo, Ohio, United States

Mercy Hospital of Tiffin

🇺🇸

Tiffin, Ohio, United States

Medical University of Ohio Cancer Center

🇺🇸

Toledo, Ohio, United States

CCOP - Toledo Community Hospital

🇺🇸

Toledo, Ohio, United States

Toledo Clinic, Incorporated - Main Clinic

🇺🇸

Toledo, Ohio, United States

St. Anne Mercy Hospital

🇺🇸

Toledo, Ohio, United States

Fulton County Health Center

🇺🇸

Wauseon, Ohio, United States

Precision Radiotherapy at University Pointe

🇺🇸

West Chester, Ohio, United States

Mount Carmel St. Ann's Cancer Center

🇺🇸

Westerville, Ohio, United States

Genesis - Good Samaritan Hospital

🇺🇸

Zanesville, Ohio, United States

Clinton Memorial Hospital

🇺🇸

Wilmington, Ohio, United States

Ruth G. McMillan Cancer Center at Greene Memorial Hospital

🇺🇸

Xenia, Ohio, United States

Providence Milwaukie Hospital

🇺🇸

Milwaukie, Oregon, United States

Geisinger Cancer Institute at Geisinger Health

🇺🇸

Danville, Pennsylvania, United States

Geisinger Hazleton Cancer Center

🇺🇸

Hazleton, Pennsylvania, United States

Frank M. and Dorothea Henry Cancer Center at Geisinger Wyoming Valley Medical Center

🇺🇸

Wilkes-Barre, Pennsylvania, United States

Geisinger Medical Group - Scenery Park

🇺🇸

State College, Pennsylvania, United States

AnMed Cancer Center

🇺🇸

Anderson, South Carolina, United States

Rapid City Regional Hospital

🇺🇸

Rapid City, South Dakota, United States

Gibbs Regional Cancer Center at Spartanburg Regional Medical Center

🇺🇸

Spartanburg, South Carolina, United States

Fredericksburg Oncology, Incorporated

🇺🇸

Fredericksburg, Virginia, United States

Southwest Washington Medical Center Cancer Center

🇺🇸

Vancouver, Washington, United States

Luther Midlelfort Hospital

🇺🇸

Eau Claire, Wisconsin, United States

Midelfort Clinic - Luther

🇺🇸

Eau Claire, Wisconsin, United States

Holy Family Memorial Medical Center Cancer Care Center

🇺🇸

Manitowoc, Wisconsin, United States

St. Mary's Hospital Medical Center - Green Bay

🇺🇸

Green Bay, Wisconsin, United States

Green Bay Oncology, Limited at St. Vincent Hospital Regional Cancer Center

🇺🇸

Green Bay, Wisconsin, United States

Green Bay Oncology, Limited at St. Mary's Hospital

🇺🇸

Green Bay, Wisconsin, United States

Green Bay Oncology, Limited - Oconto Falls

🇺🇸

Oconto Falls, Wisconsin, United States

Bay Area Cancer Care Center at Bay Area Medical Center

🇺🇸

Marinette, Wisconsin, United States

St. Vincent Hospital Regional Cancer Center

🇺🇸

Green Bay, Wisconsin, United States

Green Bay Oncology, Limited - Sturgeon Bay

🇺🇸

Sturgeon Bay, Wisconsin, United States

St. James Healthcare Cancer Care

🇺🇸

Butte, Montana, United States

Great Falls Clinic - Main Facility

🇺🇸

Great Falls, Montana, United States

Northern Rockies Radiation Oncology Center

🇺🇸

Billings, Montana, United States

St. Vincent Healthcare Cancer Care Services

🇺🇸

Billings, Montana, United States

Billings Clinic - Downtown

🇺🇸

Billings, Montana, United States

Bozeman Deaconess Cancer Center

🇺🇸

Bozeman, Montana, United States

St. Peter's Hospital

🇺🇸

Helena, Montana, United States

Northern Montana Hospital

🇺🇸

Havre, Montana, United States

Glacier Oncology, PLLC

🇺🇸

Kalispell, Montana, United States

Kalispell Medical Oncology at KRMC

🇺🇸

Kalispell, Montana, United States

Kalispell Regional Medical Center

🇺🇸

Kalispell, Montana, United States

Community Medical Center

🇺🇸

Missoula, Montana, United States

Guardian Oncology and Center for Wellness

🇺🇸

Missoula, Montana, United States

Montana Cancer Specialists at Montana Cancer Center

🇺🇸

Missoula, Montana, United States

Medical X-Ray Center, PC

🇺🇸

Sioux Falls, South Dakota, United States

CCOP - Upstate Carolina

🇺🇸

Spartanburg, South Carolina, United States

Sanford Cancer Center at Sanford USD Medical Center

🇺🇸

Sioux Falls, South Dakota, United States

Virginia Piper Cancer Institute at Abbott - Northwestern Hospital

🇺🇸

Minneapolis, Minnesota, United States

Hennepin County Medical Center - Minneapolis

🇺🇸

Minneapolis, Minnesota, United States

Charles M. Barrett Cancer Center at University Hospital

🇺🇸

Cincinnati, Ohio, United States

Cancer Center of Kansas, PA - Wichita

🇺🇸

Wichita, Kansas, United States

Associates in Womens Health, PA - North Review

🇺🇸

Wichita, Kansas, United States

Cancer Center of Kansas, PA - Chanute

🇺🇸

Chanute, Kansas, United States

Cancer Center of Kansas, PA - Kingman

🇺🇸

Kingman, Kansas, United States

CCOP - MeritCare Hospital

🇺🇸

Fargo, North Dakota, United States

Cancer Center of Kansas, PA - Dodge City

🇺🇸

Dodge City, Kansas, United States

CCOP - Wichita

🇺🇸

Wichita, Kansas, United States

Cancer Center of Kansas, PA - El Dorado

🇺🇸

El Dorado, Kansas, United States

Lawrence Memorial Hospital

🇺🇸

Lawrence, Kansas, United States

Cancer Center of Kansas - Fort Scott

🇺🇸

Fort Scott, Kansas, United States

Via Christi Cancer Center at Via Christi Regional Medical Center

🇺🇸

Wichita, Kansas, United States

Cancer Center of Kansas, PA - Newton

🇺🇸

Newton, Kansas, United States

Cancer Center of Kansas, PA - Parsons

🇺🇸

Parsons, Kansas, United States

Cancer Center of Kansas, PA - Pratt

🇺🇸

Pratt, Kansas, United States

Cancer Center of Kansas, PA - Wellington

🇺🇸

Wellington, Kansas, United States

Rocky Mountain Oncology

🇺🇸

Casper, Wyoming, United States

Providence Cancer Center at Providence Portland Medical Center

🇺🇸

Portland, Oregon, United States

Adventist Medical Center

🇺🇸

Portland, Oregon, United States

Legacy Good Samaritan Hospital & Comprehensive Cancer Center

🇺🇸

Portland, Oregon, United States

Northwest Cancer Specialists at Rose Quarter Cancer Center

🇺🇸

Portland, Oregon, United States

CCOP - Columbia River Oncology Program

🇺🇸

Portland, Oregon, United States

Providence St. Vincent Medical Center

🇺🇸

Portland, Oregon, United States

Knight Cancer Institute at Oregon Health and Science University

🇺🇸

Portland, Oregon, United States

UVMC Cancer Care Center at Upper Valley Medical Center

🇺🇸

Troy, Ohio, United States

CCOP - Michigan Cancer Research Consortium

🇺🇸

Ann Arbor, Michigan, United States

Creighton University Medical Center

🇺🇸

Omaha, Nebraska, United States

Saint Joseph Mercy Cancer Center

🇺🇸

Ann Arbor, Michigan, United States

Mayo Clinic Cancer Center

🇺🇸

Rochester, Minnesota, United States

CCOP - Missouri Valley Cancer Consortium

🇺🇸

Omaha, Nebraska, United States

Immanuel Medical Center

🇺🇸

Omaha, Nebraska, United States

Alegant Health Cancer Center at Bergan Mercy Medical Center

🇺🇸

Omaha, Nebraska, United States

Cancer Resource Center - Lincoln

🇺🇸

Lincoln, Nebraska, United States

Mercy Capitol Hospital

🇺🇸

Des Moines, Iowa, United States

CCOP - Iowa Oncology Research Association

🇺🇸

Des Moines, Iowa, United States

John Stoddard Cancer Center at Iowa Methodist Medical Center

🇺🇸

Des Moines, Iowa, United States

Medical Oncology and Hematology Associates at John Stoddard Cancer Center

🇺🇸

Des Moines, Iowa, United States

Medical Oncology and Hematology Associates at Mercy Cancer Center

🇺🇸

Des Moines, Iowa, United States

John Stoddard Cancer Center at Iowa Lutheran Hospital

🇺🇸

Des Moines, Iowa, United States

Mercy Cancer Center at Mercy Medical Center - Des Moines

🇺🇸

Des Moines, Iowa, United States

Drs. Carrol, Sheth, Raghavan

🇺🇸

Louisville, Kentucky, United States

Hematology-Oncology Centers of the Northern Rockies - Billings

🇺🇸

Billings, Montana, United States

Cancer Center of Kansas, PA - Winfield

🇺🇸

Winfield, Kansas, United States

Mercy Medical Center

🇺🇸

Springfield, Ohio, United States

Welch Cancer Center at Sheridan Memorial Hospital

🇺🇸

Sheridan, Wyoming, United States

© Copyright 2025. All Rights Reserved by MedPath